Search
for
Sort by
Research 901–930 of 1000+
- Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
- Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Platelet-Rich Plasma in Alopecia Areata—A Steroid-Free Treatment Modality: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- Role of Hair Prostheses (Wigs) in Patients with Severe Alopecia Areata
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Rethinking the classification of alopecia areata
- Serum level of vitamin D in patients with alopecia areata
- Assessment of Vitamin D Level in Patients of Alopecia Areata
- Successful treatment of resistant alopecia areata with a phototoxic dose of ultraviolet A after topical 8‐methoxypsoralen application
- Association between ovarian volume and serum insulin levels in ovulatory patients with idiopathic hirsutism
- Innovative method of alopecia treatment by autologous adipose-derived SVF
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Response of alopecia areata of the beard to oral tofacitinib
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
- Allergen desensitization reduces the severity of relapsed alopecia areata in dust‐mite allergic patients
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population